Held on 29 June 2017 in Barcelona, Spain, the Optimizing the Continuum of Care for Patients with Pancreatic Cancer symposium explored updated standards of care for treatment sequencing for pancreatic carcinoma. Utilizing a case based approach, this activity assesses the use of adjuvant chemotherapy at relapse, examines the optimal approach for patients with borderline resectable disease, and probes how the management of locally advanced pancreatic cancer impacts treatment decisions in the metastatic setting.
This symposium was organized by: Celgene International Sàrl.
This satellite symposium was held in conjunction with the ESMO 19th World Congress on Gastrointestinal Cancer. The symposium content is not an official part of the World Congress' scientific program, nor is it organized or endorsed by Imedex.